Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Foviscu (WCK 4282) - Phase 3 Ongoing First-line empiric treatment for gram-negative hospital infections (cUTI, HABP/VABP) Complements ZAYNICH: while ZAYNICH is the destination therapy at the top of the pyramid for resistant infections, Foviscu is the entry-level, broad-use first drug of choice Global Phase 3 trial underway If approved, the commercial TAM is significantly larger than ZAYNICH due to broader use 5
Avoid touching the medicine or sticky adhesive
IIH Pressure Med: A randomised, sequential, trial of the effect on intracranial pressure of five drugs commonly used in Idiopathic Intracranial Hypertension [abstract]
Oral semaglutide works in phases
US$ 24.45
US$ 29.08
US$ 24.68
US$ 27.70
US$ 21.88
.jpg)
